Summary
Background
Previous studies suggested a protective effect of smoking on Alzheimer's disease, but most were case-control studies based on prevalent cases. The findings of prospective studies on the association between smoking and the risk of dementia are inconclusive.
Methods
We did a population-based follow-up study of elderly people who were initially free of dementia. 6870 people aged 55 years and older agreed to take part. Smoking history was taken at baseline and participants were classified as never smokers, former smokers, and current smokers. During follow-up, we recorded all incident cases of dementia. We used never smokers as the reference category to calculate relative risks of dementia and Alzheimer's disease by Cox proportional hazards regression, after adjustment for age, sex, education, and alcohol intake. We also examined modification of risk by age, sex, and the apolipoprotein E (APOE) genotype.
Findings
During mean follow-up of 2·1 (range 1·5–3·4) years, 146 incident cases of dementia were detected, of which 105 were Alzheimer's disease. Compared with never smokers, smokers had an increased risk of dementia (relative risk 2·2 [95% CI 1·3–3·6]) and Alzheimer's disease (2·3 [1·3–4·1]). Smoking was a strong risk factor for Alzheimer's disease in individuals without the APOE€4 allele (4·6 [1·5–14·2]), but had no effect in participants with this allele (0·6 [0·1–4·8]).
Interpretation
Smoking was associated with a doubling of the risk of dementia and Alzheimer's disease. Our finding that carriers of the APOE€4 had no increased risk of dementia suggests an interaction between smoking and the APOE€4 genotype in the aetiology of Alzheimer's disease.
This article is available free of charge.
Simply log in to access the full article, or register for free if you do not yet have a username and password.
Already registered?
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Not yet registered?
Register for free
References
- 1.
Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study.BMJ. 1995; 310: 970-973
- 2.
The human costs of tobacco use (1).N Engl J Med. 1994; 330: 907-912
- 3.
Meta-analysis of the relation between cigarette smoking and stroke.BMJ. 1989; 298: 789-794
- 4.
Acute effects of smoking on blood pressure and cerebral blood flow.J Hum Hypertens. 1989; 3: 443-449
- 5.
β-amyloid-mediated vasoactivity and vascular endothelial damage.Nature. 1996; 380: 168-171
- 6.
Atherosclerosis, apolipoprotein E, and the prevalence of dementia and Alzheimer's disease in the Rotterdam Study.Lancet. 1997; 349: 151-154
- 7.
Preventable senility: a call for action against the vascular dementias.Lancet. 1992; 340: 645-648
- 8.
Smoking and Alzheimer's disease: a review of the epidemiological evidence.Neuroepidemiology. 1994; 13: 131-144
- 9.
Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease.BMJ. 1995; 310: 627-631
- 10.
Smoking and Alzheimer's disease: protective effect or differential survival bias?.Lancet. 1993; 342: 793-794
- 11.
Mortality in relation to smoking: 40 years' observations on male British doctors.BMJ. 1994; 309: 901-911
- 12.
Determinants of disease and disability in the elderly. The Rotterdam Elderly Study.Eur J Epidemiol. 1991; 7: 403-422
- 13.
The incidence and risk of dementia. The Rotterdam Study.Am J Epidemiol. 1998; 147: 574-580
- 14.
“Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician.J Psychiat Res. 1975; 12: 189-198
- 15.
A semi-structured clinical interview for the assessment of diagnosis and mental state in the elderly. The Geriatric Mental State Schedule I. Development and reliability.Psychol Med. 1976; 6: 439-449
- 16. Diagnostic and statistical manual of mental disorders, 3rd edn, rev. American Psychiatric Association, Washington DC1987
- 17.
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.Neurology. 1984; 34: 939-944
- 18.
Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.Neurology. 1993; 43: 250-260
- 19.
Dietary electrolyte intake and blood pressure in older subjects: the Rotterdam Study.J Hypertens. 1996; 14: 737-741
- 20.
Apolipoprotein E genotyping by one-stage PCR.Lancet. 1991; 337: 1158-1159
- 21.
Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area.Rev Neurol (Paris). 1997; 153: 185-192
- 22.
Aetiological considerations and risk factors for multi-infarct dementia.J Neurol Neurosurg Psychiatry. 1988; 51: 1489-1497
- 23.
Risk factors for dementia associated with multiple cerebral infarcts. A case-control analysis in predominantly African-American hospital-based patients.Arch Neurol. 1993; 50: 714-720
- 24.
Relation of smoking and alcohol consumption to incident Alzheimer's disease.Am J Epidemiol. 1992; 135: 347-355
- 25.
Relationship between cigarette smoking and Alzheimer's disease in a population-based case-control study.Neurology. 1993; 43: 293-300
- 26.
Risk factors for Alzheimer's disease and dementia: a case-control study based on the MRC elderly hypertension trial.Neurology. 1994; 44: 97-104
- 27.
Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study.Neurology. 1995; 45: 1161-1168
- 28.
Apolipoprotein E alleles and risk of coronary disease: a meta-analysis.Arterioscler Thromb Vasc Biol. 1996; 16: 1250-1255
- 29.
Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease.Proc Natl Acad Sci USA. 1995; 92: 12260-12264
Article info
Publication history
Published: 20 June 1998
Identification
Copyright
© 1998 Elsevier Ltd. All rights reserved.